High Blood Pressure

Clinical Trial Finder

Many patients with high blood pressure are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Validation of a Hypertension Education Program

Condition:   Arterial Hypertension
Intervention:   Behavioral: Interactive hypertension education program of the DHL©
Sponsor:   Charite University, Berlin, Germany
Recruiting - verified February 2016

Mechanical Ventilation in Severe Brain Injury: The Effect of Positive End Expiratory Pressure on Intracranial Pressure

Conditions:   Intracranial Hypertension;   Critical Illness;   Brain Injuries;   Lung Injury;   Respiratory Failure;   Positive-Pressure Respiration, Intrinsic
Intervention:   Other: PEEP titrated mechanical ventilation
Sponsors:   Beth Israel Deaconess Medical Center;   Center for Anesthesia Research Excellence (CARE), Beth Israel Deaconess Medical Center
Not yet recruiting - verified February 2016

Renal Denervation for the Treatment of Hypertension: A Pilot Safety and Efficacy Study

Condition:   Hypertension
Intervention:   Device: Radio frequency renal denervation system (Golden Leaf GL-06E15A)
Sponsor:   Shanghai Golden Leaf MedTec Co. Ltd
Recruiting - verified February 2016

A Study to Investigate the Effect of a Nitric Oxide Supplementation on Pre- and Mildly Hypertensive Adults

Condition:   Pre-hypertension
Interventions:   Dietary Supplement: Neo40 Daily®;   Dietary Supplement: Placebo
Sponsors:   KGK Synergize Inc.;   Neogenis Laboratories
Recruiting - verified February 2016

Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension

Conditions:   Open-angle Glaucoma;   Ocular Hypertension
Interventions:   Drug: PG324 Ophthalmic Solution;   Drug: Netarsudil (AR-13324) ophthalmic solution;   Drug: Latanoprost ophthalmic solution
Sponsor:   Aerie Pharmaceuticals
Not yet recruiting - verified February 2016

Serelaxin To Lower Portal Pressure

Conditions:   Liver Cirrhosis;   Hypertension, Portal
Interventions:   Drug: Serelaxin;   Drug: Placebo
Sponsors:   University of Edinburgh;   Novartis Pharmaceuticals;   NHS Lothian
Not yet recruiting - verified December 2015

Effects of Aerobic Exercise on Blood Pressure Levels of Resistant Hypertensive Subjects

Conditions:   Hypertension;   Resistant Hypertension
Intervention:   Behavioral: Aerobic Exercise Training
Sponsor:   Federal University of Paraíba
Recruiting - verified February 2016

Association Between Vitamin D Deficiency and Preeclampsia: A Case Control Study

Condition:   Pre-Eclampsia
Intervention:  
Sponsor:   Ain Shams Maternity Hospital
Completed - verified February 2016

Antihypertensive Effect of Fermented Milk With Lactococcus Lactis on Prehypertensive Subjects

Condition:   Hypertension
Interventions:   Dietary Supplement: Fermented milk;   Dietary Supplement: Acidified milk
Sponsor:   Centro de Investigación en Alimentación y Desarrollo A.C.
Completed - verified February 2016

A ED-based Intervention to Improve Antihypertensive Adherence

Conditions:   Hypertensive Emergency;   Hypertension;   Blood Pressure
Interventions:   Behavioral: ED-based behavioral intervention;   Behavioral: ED usual care plus education
Sponsors:   Vanderbilt University;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified January 2016

Fesoterodine for Amelioration of Autonomic Dysreflexia (AD) Following Spinal Cord Injury (SCI)

Condition:   Autonomic Dysreflexia
Intervention:   Drug: Fesoterodine
Sponsors:   University of British Columbia;   Pfizer;   International Collaboration On Repair Discoveries (ICORD);   Vancouver Coastal Health
Not yet recruiting - verified February 2016

Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle Glaucoma

Conditions:   Glaucoma, Open-Angle;   Glaucoma, Primary Open Angle;   Exfoliation Glaucoma;   Glaucoma, Pigmentary
Intervention:  
Sponsor:   Fundación Oftalmológica Nacional
Recruiting - verified February 2016

Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST

Condition:   Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Interventions:   Drug: Placebo capsules;   Drug: Bardoxolone methyl capsules
Sponsor:   Reata Pharmaceuticals, Inc.
Not yet recruiting - verified February 2016

Clinical Research to Explore Manifestations of Heart Failure Using Infrared Thermal Imaging Technology

Condition:   Heart Failure,Congestive
Intervention:  
Sponsor:   Jing Huang
Recruiting - verified February 2016

OCEAN Registry: Obesity and Clock for Elegant Aging Registry

Conditions:   Obesity;   Circadian Dysregulation;   Aging;   Cardiovascular Disease
Intervention:  
Sponsor:   Chang Gung Memorial Hospital
Recruiting - verified February 2016

Evaluation of Corneal Temperature by Infrared Thermography in Glaucoma Patients

Condition:   Glaucoma
Intervention:   Device: infrared thermography
Sponsor:   University Hospital, Basel, Switzerland
Completed - verified February 2016

Comparative Effectiveness of Health System vs. Multilevel Interventions to Reduce Hypertension Disparities

Condition:   Uncontrolled Hypertension
Interventions:   Behavioral: Provider Audit-Feedback;   Behavioral: Provider Audit-Feedback, Stratified by race, ethnicity, payor status;   Behavioral: Blood Pressure Measurement Standardization;   Behavioral: System Level Leadership Intervention;   Behavioral: Collaborative Care Team Intervention;   Behavioral: Community Health Worker;   Behavioral: Specialist Care
Sponsors:   Johns Hopkins University;   National Heart, Lung, and Blood Institute (NHLBI);   Mid-Atlantic Association of Community Health Centers;   Patient-Centered Outcomes Research Institute
Not yet recruiting - verified February 2016

Metabolic Effects of Angiotensin-(1-7)

Conditions:   Obesity;   Insulin Resistance;   Hypertension;   Metabolic Cardiovascular Syndrome
Interventions:   Drug: Angiotensin-(1-7);   Drug: Saline
Sponsor:   Vanderbilt University
Recruiting - verified February 2016

A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension

Condition:   Pulmonary Arterial Hypertension
Intervention:   Drug: Tocilizumab
Sponsors:   Papworth Hospital NHS Foundation Trust;   Roche Pharma AG;   National Institute for Health Research, United Kingdom
Recruiting - verified January 2016

Prognostic Observation of Posterior Reversible Encephalopathy Syndrome

Condition:   Posterior Reversible Encephalopathy Syndrome
Intervention:  
Sponsors:   Yantai Yuhuangding Hospital;   University of Southern California
Not yet recruiting - verified February 2016

A Study Investigating Routine Practice of Chronic Thromboembolic Pulmonary Hypertension Management in EMEA Countries

Condition:   Hypertension, Pulmonary
Intervention:   Other: Standard of care
Sponsor:   Bayer
Not yet recruiting - verified February 2016

Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Conditions:   Pulmonary Hypertension;   Pulmonary Fibrosis
Intervention:   Drug: Oral treprostinil
Sponsor:   United Therapeutics
Withdrawn - verified February 2016

Effects of Speech-therapy in Hypertensive Patients

Condition:   Hypertension
Intervention:   Behavioral: Anthroposophic speech therapy
Sponsors:   Klinik Arlesheim;   Paracelsus-Spital Richterswil;   University of Bern
Completed - verified February 2016

The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment

Conditions:   Homocysteine;   Coronary Disease;   Angioplasty,Balloon,Coronary;   Contrast Media;   Nephropathy;   Hypertension
Interventions:   Drug: Enalapril Maleate Tablets(as the program-based antihypertension);   Drug: Enalapril Maleate and Folic Acid tablets(as the program-based antihypertension);   Drug: Placebo
Sponsor:   Fuling Central Hospital of Chongqing City
Recruiting - verified February 2016

The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With Type 1 Diabetes Mellitus (T1DM)

Condition:   Type 1 Diabetes Mellitus
Interventions:   Drug: Dapagliflozin 5 mg;   Drug: Dapagliflozin 10mg
Sponsor:   AstraZeneca
Recruiting - verified February 2016

Evaluation of the Effectiveness of Non-invasive Ventilation on the Reperfusion Pulmonary Edema Post Pulmonary Artery Angioplasty in the Post Embolic Pulmonary Hypertension

Condition:   Reperfusion Pulmonary Edema
Interventions:   Other: Blood samples for assays of plasma inflammatory markers (cytokines InterLeukin-6, InterLeukin-8, InterLeukin-10);   Procedure: Non invasive ventilation;   Procedure: monitoring system Pulse-Induced Contour Cardiac Output (Picco);   Procedure: Computed tomography (CT)
Sponsor:   Centre Chirurgical Marie Lannelongue
Not yet recruiting - verified February 2016

EUS-guided Glue Injection for Varices Study

Condition:   Gastroesophageal Varices
Intervention:   Procedure: EUS-guided glue injection
Sponsor:   Chinese University of Hong Kong
Recruiting - verified January 2016

Electronic Activity Level Monitoring Pilot in Pulmonary Hypertension

Conditions:   Pulmonary Hypertension;   Hypertension, Pulmonary
Intervention:   Other: Correlation assessment
Sponsor:   Bayer
Recruiting - verified February 2016

Early Vascular Adjustments During Hypertensive Pregnancy

Conditions:   Hypertension, Pregnancy-Induced;   Pre-Eclampsia
Interventions:   Drug: Labetalol;   Drug: Nifedipine;   Drug: Methyldopa
Sponsor:   Maastricht University Medical Center
Recruiting - verified February 2016

Operative Procedures vs. Endovascular Neurosurgery for Untreated Pseudotumor Trial

Conditions:   Pseudotumor Cerebri;   Idiopathic Intracranial Hypertension (IIH)
Interventions:   Procedure: Dural Venous Sinus Stenting;   Procedure: Cerebrospinal Fluid Shunting
Sponsor:   St. Joseph's Hospital and Medical Center, Phoenix
Recruiting - verified February 2016

Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 and 40.0

Conditions:   Myelomeningocele;   Pregnancy
Intervention:   Procedure: Open Fetal Repair of Myelomeningocele
Sponsor:   St. Louis University
Recruiting - verified February 2016

Addressing Racial/Ethnic Tobacco Health Disparities Via Group Intervention

Condition:   Smoking Cessation
Interventions:   Behavioral: Group Cognitive Behavioral Therapy;   Behavioral: General Health Education;   Drug: Transdermal Nicotine Patch
Sponsors:   University of Miami;   H. Lee Moffitt Cancer Center and Research Institute
Recruiting - verified February 2016

ALLiance for sEcondary PREvention After an Episode of Acute Coronary Syndrome (ALLEPRE)

Condition:   Acute Coronary Syndrome
Interventions:   Behavioral: Nurse-led Intensive Secondary Prevention Programme;   Behavioral: Usual Treatment
Sponsor:   Azienda Ospedaliero-Universitaria di Parma
Recruiting - verified February 2016

Southwest Health Extension Partnership to Enhance Research Dissemination

Condition:   Cardiovascular Diseases
Interventions:   Other: Enhanced practice transformation support;   Other: Standard practice transformation support
Sponsors:   University of Colorado, Denver;   University of New Mexico
Recruiting - verified February 2016

Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension

Condition:   Pulmonary Arterial Hypertension
Interventions:   Procedure: denervation;   Procedure: sham procedure
Sponsors:   Centre Hospitalier Universitaire de Nice;   Assistance Publique Hopitaux De Marseille;   University Hospital, Toulouse;   University Hospital, Grenoble;   Assistance Publique - Hôpitaux de Paris
Active, not recruiting - verified February 2016

Renal Nerves Stimulation Study

Conditions:   Hypertension;   Renal Denervation
Intervention:   Procedure: Electrical mapping, nerve stimulation and renal denervation procedure
Sponsor:   Diagram B.V.
Recruiting - verified February 2016

The Effects of CPAP Withdrawal on Cerebral Vascular Reactivity and Brain Oxygenation in OSA

Condition:   Sleep Apnea, Obstructive
Intervention:   Device: Continuous positive airway pressure device
Sponsor:   University of Zurich
Recruiting - verified February 2016

Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis

Condition:   Hypertension, Portal
Interventions:   Drug: GR-MD-02;   Drug: Placebo
Sponsors:   Galectin Therapeutics Inc.;   Brooke Army Medical Center, Stephen A. Harrison, MD;   Indiana University, Naga Chalasani, MD
Recruiting - verified September 2015

An Observational Cross-sectional Study Evaluating the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism, Who Are on Treatment to Adequately Control Their Coagulation and Treated in Primary Care Centres

Conditions:   Stroke;   Prevention and Control;   Atril Fibrillation
Intervention:   Drug: Direct oral anticoagulants
Sponsor:   Bayer
Active, not recruiting - verified February 2016

EMPower: Electronic Media Powering Positive Health Changes in Youth

Conditions:   Hypertension;   Prehypertension;   Overweight;   Obesity;   Hypertrophy, Left Ventricular
Interventions:   Behavioral: Electronic Media Application;   Behavioral: Standard of care education
Sponsors:   Johns Hopkins University;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2016

SPYRAL HTN-ON MED Study

Conditions:   Hypertension;   Vascular Diseases;   Cardiovascular Diseases
Interventions:   Device: Symplicity Spyral™ multi-electrode renal denervation system;   Procedure: Sham Procedure
Sponsor:   Medtronic Vascular
Recruiting - verified February 2016

SPYRAL HTN-OFF MED Study

Conditions:   Hypertension;   Vascular Diseases;   Cardiovascular Diseases
Interventions:   Device: Symplicity Spyral™ multi-electrode renal denervation system;   Procedure: Sham Procedure
Sponsor:   Medtronic Vascular
Recruiting - verified February 2016

Effectiveness of Prazosin on the Urinary Sodium Excretion Response to Mental Stress

Conditions:   Hypertension;   Stress, Psychological;   Blood Pressure
Interventions:   Drug: Prazosin;   Drug: Placebo
Sponsor:   Georgia Regents University
Recruiting - verified February 2016

Study Comparing Lutonix AV Drug Coated Balloon vs Standard Balloon for Treatment of Dysfunctional AV Fistulae

Condition:   Arteriovenous Fistula
Interventions:   Device: Lutonix DCB;   Device: Standard Balloon Angioplasty Catheter
Sponsor:   C. R. Bard
Recruiting - verified February 2016

Impact of Community Health Workers on Adherence to Therapy for Non-Communicable Chronic Disease in Chiapas, Mexico

Conditions:   Hypertension;   Diabetes Mellitus, Type 2
Intervention:  
Sponsors:   Brigham and Women's Hospital;   Harvard University
Active, not recruiting - verified February 2016

Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress

Conditions:   Psychological Stress;   Hypertension, Renal
Interventions:   Drug: mycophenolate mofetil (MMF);   Drug: Placebo
Sponsor:   Georgia Regents University
Recruiting - verified February 2016

Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension

Condition:   Hypertension
Intervention:   Drug: Trimethaphan
Sponsor:   Vanderbilt University
Recruiting - verified February 2016

Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapyo-therapy.

Condition:   Hypertension
Intervention:   Drug: Nifedipine(Adalat_BAY1040)
Sponsor:   Bayer
Recruiting - verified February 2016

Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy

Condition:   Primary Open Angle Glaucoma
Interventions:   Drug: TGF-β2 antisense oligonucleotide;   Procedure: Trabeculectomy
Sponsor:   Isarna Therapeutics GmbH
Recruiting - verified February 2016

Effectiveness of Avapro in Obese Normotensive/Hypertensive African Americans

Conditions:   Hypertension;   Obesity;   Stress, Psychological;   Blood Pressure
Interventions:   Drug: Irbesartan;   Drug: Placebo
Sponsor:   Georgia Regents University
Recruiting - verified February 2016

Longitudinal Study: Diagnosis and Prediction of Pre-Eclampsia by Using Congo Red Dot Test in Bangladesh and Mexico

Condition:   Preeclampsia
Intervention:   Device: Congo Red Dot test
Sponsors:   Gynuity Health Projects;   Nationwide Children's Hospital
Not yet recruiting - verified February 2016

TIPS in Fundal Variceal Bleeding (the TFB Study)

Conditions:   Portal Hypertension;   Bleeding Gastric Varices
Intervention:   Device: Early TIPS
Sponsors:   Institut d'Investigacions Biomèdiques August Pi i Sunyer;   Hospital Clinic of Barcelona;   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau;   Germans Trias i Pujol Hospital;   Hospital Universitario Ramon y Cajal;   Hospital del Mar
Recruiting - verified February 2016

A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects

Condition:   Essential Hypertension
Interventions:   Drug: CS-3150;   Drug: placebo;   Drug: eplerenone
Sponsor:   Daiichi Sankyo Inc.
Completed - verified February 2016

Low Dose Calcium to Prevent Preeclampsia

Conditions:   Pre-Eclampsia;   Hypertension, Pregnancy-Induced;   Dietary Calcium Deficiency
Interventions:   Dietary Supplement: calcium;   Behavioral: Educational sessions
Sponsors:   Federal University of São Paulo;   PPSUS (Programa Pesquisa para o SUS: gestão compartilhada em saúde);   FAPEAM (Fundação de Amparo a Pesquisa do Estado do Amazonas);   Universidade Federal do Amazonas
Recruiting - verified February 2016

Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies

Conditions:   Acute Lymphoblastic Leukemia/Lymphoma;   Myelodysplasia;   Acute Myelogenous Leukemia;   Juvenile Myelomonocytic Leukemia;   Chronic Myelogenous Leukemia
Intervention:  
Sponsors:   Center for International Blood and Marrow Transplant Research;   Pediatric Blood and Marrow Transplant Consortium;   National Marrow Donor Program
Recruiting - verified February 2016

Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension

Conditions:   Glaucoma;   Ocular Hypertension
Interventions:   Drug: OTX-TP;   Drug: Timolol
Sponsor:   Ocular Therapeutix, Inc.
Active, not recruiting - verified February 2016

Physical Exercise Prescription With PEdometeR in General Practice for Patients With Cardiovascular Risk Factors - The PEPPER Pragmatic Trial

Conditions:   Sedentary Lifestyle;   Cardiovascular Diseases;   Hypertension;   Hypercholesterolemia;   Diabetes Mellitus, Type 2
Interventions:   Behavioral: Intervention PPIL;   Behavioral: Control OR
Sponsor:   University Hospital, Angers
Recruiting - verified February 2016

A Proof of Concept Study of Electrical Discharge Produced Nitric Oxide for Inhalation

Condition:   Hypertension, Pulmonary
Intervention:   Device: electrical pulsed plasma discharge synthesis of nitric oxide
Sponsor:   Massachusetts General Hospital
Completed - verified February 2016

Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

Condition:   Carcinoma, Non-Small-Cell Lung
Interventions:   Drug: Chemotherapy;   Drug: BI 695502;   Drug: bevacizumab;   Drug: Chemotherapy
Sponsor:   Boehringer Ingelheim
Recruiting - verified February 2016

The SCCS Polypill Pilot Trial

Conditions:   Hypertension;   Hyperlipidemia
Intervention:   Drug: Polypill (atorvastatin, amlodipine, losartan, and hydrochlorothiazide)
Sponsor:   Vanderbilt University
Recruiting - verified February 2016

Red Blood Cells as a Reflection of Endothelial Function in Old Age

Conditions:   Red Blood Cells;   Endothelial Function;   Nitric Oxide Pool in Red Blood Cells and Blood Plasma
Intervention:  
Sponsor:   Heinrich-Heine University, Duesseldorf
Recruiting - verified October 2015

Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial Hypertension

Condition:   Arterial Hypertension
Interventions:   Drug: Fimasartan;   Drug: Losartan
Sponsors:   R-Pharm;   Covance;   Boryung Pharmaceutical Co., Ltd
Completed - verified February 2016

Metformin in Kidney Disease

Conditions:   Chronic Kidney Disease;   Cardiovascular Disease;   Metabolic Syndrome
Interventions:   Drug: metformin;   Drug: Placebo
Sponsor:   VA Office of Research and Development
Recruiting - verified February 2016

Human Intervention Study of Egg Protein Derivative on Cardiovascular Risk

Condition:   Hypertension
Intervention:   Dietary Supplement: Egg albumin-derived peptide
Sponsor:   University College Cork
Completed - verified February 2016

Azilsartan Medoxomil (TAK-491) Compared to Placebo in Korean Adults With Hypertension

Condition:   Hypertension
Interventions:   Drug: Azilsartan medoxomil;   Drug: Azilsartan medoxomil placebo
Sponsor:   Takeda
Completed - verified February 2016

24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension

Conditions:   Diabetes Mellitus, Type 2;   Hypertension
Interventions:   Drug: Empagliflizon low dose;   Drug: placebo;   Drug: Empagliflizon high dose
Sponsors:   Boehringer Ingelheim;   Eli Lilly and Company
Recruiting - verified February 2016

Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive Therapy

Condition:   Hypertension
Interventions:   Drug: Over-encapsulated 10 mg amlodipine besylate tablet;   Drug: Matched placebo capsule for over-encapsulated celecoxib capsule;   Drug: Over-encapsulated 200 mg celecoxib capsule;   Drug: Matched placebo tablet for over-encapsulated amlodipine besylate tablet
Sponsor:   Kitov Pharmaceuticals, Ltd.
Completed - verified February 2016

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis.

Condition:   Anemia
Interventions:   Drug: Roxadustat;   Drug: Placebo
Sponsors:   AstraZeneca;   FibroGen
Recruiting - verified February 2016

Portal Hypertension and Liver Resection in Patients With Hepatocellular Carcinoma

Condition:   Primary Liver Cancers
Intervention:   Procedure: Liver resection
Sponsor:   Henri Mondor University Hospital
Recruiting - verified February 2016

Heart Health 4 Moms

Conditions:   Cardiovascular Disease;   Preeclampsia;   Hypertension;   Post-partum Weight Retention
Interventions:   Behavioral: Web-based educational and motivational modules;   Behavioral: Information and Screening Group
Sponsors:   Brigham and Women's Hospital;   Patient-Centered Outcomes Research Institute;   Preeclampsia Foundation
Recruiting - verified February 2016

An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product

Conditions:   Primary Open-Angle Glaucoma;   Ocular Hypertension
Intervention:   Drug: ForSight VISION5 Product
Sponsor:   ForSight Vision5, Inc.
Completed - verified February 2016

Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)

Condition:   Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary
Interventions:   Drug: Adempas, Riociguat (BAY63-2521);   Device: Placebo
Sponsor:   Bayer
Recruiting - verified February 2016

Registro Campania Salute Network on Hypertension

Condition:   Hypertension; Heart Disease, Hypertensive
Intervention:  
Sponsor:   Federico II University
Recruiting - verified February 2016

Endothelin Receptor Function and Acute Stress

Condition:   Hypertension
Interventions:   Drug: Bosentan;   Drug: Placebo
Sponsors:   Georgia Regents University;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2016

The Effects of Strawberries on Blood Pressure in Postmenopausal Women

Conditions:   Hypertension;   Cardiovascular Diseases;   Vascular Diseases
Interventions:   Dietary Supplement: 25 g of Freeze-dried Strawberry Powder;   Dietary Supplement: 50 g of Freeze-dried Strawberry Powder;   Dietary Supplement: Placebo Powder
Sponsors:   Florida State University;   California Strawberry Commission
Completed - verified February 2016

A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R

Condition:   Essential Hypertension Complicated by Type 2 Diabetes Mellitus
Interventions:   Drug: Azilsartan;   Drug: Telmisartan
Sponsor:   Takeda
Recruiting - verified February 2016

Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

Condition:   Carotid Stenosis
Interventions:   Procedure: Carotid endarterectomy;   Device: Carotid stenting
Sponsors:   Thomas G. Brott, M.D.;   National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2016

A Trial Comparing Treatment With the Springfusor Infusion Pump to the IV Magnesium Sulfate Regimen

Condition:   Preeclampsia
Interventions:   Device: Springfusor infusion pump;   Other: IV administration;   Drug: Magnesium Sulfate
Sponsor:   Gynuity Health Projects
Recruiting - verified February 2016

Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer

Condition:   Carcinoma, Hepatocellular
Interventions:   Drug: Everolimus;   Drug: Tacrolimus;   Drug: Myfortic;   Drug: CellCept
Sponsor:   Baylor Research Institute
Recruiting - verified February 2016

Analysis of Aqueous and Vitreous Humor

Conditions:   Proliferative Diabetic Retinopathy;   Macular Degeneration;   Macular Hole;   Neovascular Glaucoma
Interventions:   Drug: Ranibizumab;   Other: No Ranibizumab
Sponsor:   California Retina Consultants
Recruiting - verified February 2016

Effects of Oral Sildenafil on Mortality in Adults With PAH

Condition:   Pulmonary Arterial Hypertension
Interventions:   Drug: sildenafil citrate;   Drug: sildenafil citrate;   Drug: sildenafil citrate
Sponsor:   Pfizer
Recruiting - verified February 2016

Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil

Condition:   Hypertension
Interventions:   Drug: Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106);   Drug: Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106);   Drug: Candesartan Cilexetil;   Drug: Candesartan matching placebo;   Drug: Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106) 30/16mg matching placebo;   Drug: Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106)
Sponsor:   Bayer
Not yet recruiting - verified February 2016

Rural Lifestyle Eating and Activity Program (Rural LEAP)

Condition:   Obesity
Interventions:   Behavioral: Lifestyle intervention;   Behavioral: Health education control;   Behavioral: Individual;   Behavioral: All Groups
Sponsors:   University of Florida;   National Heart, Lung, and Blood Institute (NHLBI)
Active, not recruiting - verified February 2016

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

Conditions:   Pulmonary Arterial Hypertension;   Pulmonary Hypertension
Interventions:   Drug: Bardoxolone methyl;   Drug: Placebo
Sponsor:   Reata Pharmaceuticals, Inc.
Recruiting - verified February 2016

Understanding the Exercise-Hypertension Paradox

Condition:   Hypertension
Interventions:   Dietary Supplement: Oral Antioxidant;   Other: Exercise rehabilitation
Sponsor:   VA Office of Research and Development
Recruiting - verified February 2016

Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Conditions:   Ocular Hypertension;   Open-Angle Glaucoma
Intervention:   Drug: Latanoprost Punctal Plug Delivery System (L-PPDS)
Sponsor:   Mati Therapeutics Inc.
Recruiting - verified February 2016

Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor

Condition:   Hypertension, Pulmonary
Intervention:   Drug: Riociguat (Adempas, BAY63-2521)
Sponsor:   Bayer
Active, not recruiting - verified February 2016

Essential Hypotension and Adaptability Registry

Conditions:   Blood Pressure;   Depression;   Panic Attack;   Fibromyalgia;   POTS;   Inappropriate Sinus Tachycardia;   Coronary Heart Disease;   Acute Coronary Syndrome (ACS);   Acute Myocardial Infarction (AMI);   Cerebrovascular Disease (CVD);   Transient Ischemic Attack (TIA);   Atrial Fibrillation;   Diabetes Mellitus;   Cancer;   Systolic Heart Failure;   Diastolic Heart Failure;   Chronic Fatigue Syndrome;   Syncope;   Vasovagal Syncope
Intervention:  
Sponsor:   CES University
Recruiting - verified February 2016

Beraprost-314d Added-on to Tyvaso® (BEAT)

Condition:   Pulmonary Arterial Hypertension
Interventions:   Drug: Beraprost Sodium 314d Modified Release Tablets;   Drug: Placebo
Sponsor:   Lung Biotechnology PBC
Recruiting - verified November 2015

An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.

Conditions:   Choroidal Neovascularization;   Macular Edema;   Glaucoma, Neovascular;   Diabetic Retinopathy
Intervention:   Drug: ranibizumab
Sponsor:   Novartis Pharmaceuticals
Active, not recruiting - verified February 2016

Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy

Condition:   Prostate Cancer
Interventions:   Drug: Abiraterone Acetate;   Drug: Prednisone 5 mg twice daily;   Drug: Prednisone 5 mg once daily;   Drug: Prednisone 2.5 mg twice daily;   Drug: Dexamethasone 0.5 mg once daily
Sponsor:   Janssen Pharmaceutica N.V., Belgium
Active, not recruiting - verified February 2016

A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based

Condition:   Kidney Transplantation
Interventions:   Drug: Belatacept;   Drug: Tacrolimus;   Drug: Cyclosporine
Sponsor:   Bristol-Myers Squibb
Recruiting - verified September 2015

Observational Description of Compliance for the Daily Ventavis Use Via the Insight Program in Class III Pulmonary Arterial Hypertension Patients

Condition:   Pulmonary Arterial Hypertension
Intervention:   Drug: Ventavis (Iloprost, BAYQ6256)
Sponsor:   Bayer
Active, not recruiting - verified January 2016

Evaluation of the Safety and Tolerability of Nitric Oxide (NO) Via Inhalation to Subjects With Bronchiolitis

Condition:   Bronchiolitis
Interventions:   Drug: Nitric Oxide;   Drug: Placebo
Sponsors:   Advanced Inhalation Therapies Ltd;   Soroka University Medical Center
Active, not recruiting - verified July 2015

Dexmedetomidine vs. Remifentanil for Pre-eclampsia During Caesarean Delivery

Conditions:   Pregnancy;   Severe Pre-eclampsia
Interventions:   Drug: Remifentanil;   Drug: Dexmedetomidine
Sponsor:   Mansoura University
Recruiting - verified February 2016

EBMtrialcentral- Comparing Initial Diuretic Therapies Using a Collaborative Network

Condition:   Hypertension
Interventions:   Drug: Chlorthalidone;   Drug: Hydrochlorothiazide
Sponsor:   Johns Hopkins University
Not yet recruiting - verified February 2016

A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn

Condition:   Pulmonary Hypertension, Familial Persistent, of the Newborn
Interventions:   Drug: placebo;   Drug: iv sildenafil
Sponsor:   Pfizer
Recruiting - verified February 2016

Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension

Conditions:   Pulmonary Arterial Hypertension;   Hypertension, Pulmonary
Intervention:   Drug: Sildenafil
Sponsor:   Pfizer
Recruiting - verified February 2016

Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD

Condition:   Pediatric Hypertension With or Without CKD
Interventions:   Drug: VAL489;   Drug: VAL489 matching placebo
Sponsor:   Novartis Pharmaceuticals
Recruiting - verified February 2016

Blood and Cerebrospinal Fluid for Pediatric Brain Tumor Research

Condition:   Hydrocephalus
Intervention:  
Sponsor:   Ann & Robert H Lurie Children's Hospital of Chicago
Completed - verified February 2016

Gestational Diabetes Diagnostic Methods

Condition:   Gestational Diabetes
Intervention:   Behavioral: Dietary modification and medications
Sponsor:   University of Pittsburgh
Completed - verified February 2016

Blood Vessel Study

Condition:   Endothelial Cell Function
Intervention:  
Sponsor:   National Institute of Environmental Health Sciences (NIEHS)
Enrolling by invitation - verified July 2015

A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma

Condition:   Hypertension, Glaucoma, Open-Angle
Interventions:   Drug: Placebo;   Drug: RO5093151
Sponsor:   Hoffmann-La Roche
Completed - verified February 2016

How Has Glaucoma Affected Your Quality of Life?

Conditions:   Glaucoma;   Quality of Life
Intervention:  
Sponsors:   Wills Eye;   Merck Sharp & Dohme Corp.
Active, not recruiting - verified February 2016

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Conditions:   Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention:   Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
Sponsors:   Daniel Benjamin;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   The EMMES Corporation;   OpAns, LLC
Recruiting - verified February 2016

TRANSforming InTerprofessional Cardiovascular Prevention in Primary Care

Conditions:   Diabetes Mellitus, Type 2;   Hypertension;   Dyslipidemias;   Cholesterol, LDL;   Comorbitdity
Interventions:   Other: Facilitation;   Other: Passive diffusion (usual implementation strategy)
Sponsors:   Fonds de la Recherche en Santé du Québec;   Université de Montréal
Active, not recruiting - verified February 2016

Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program

Condition:   Pulmonary Arterial Hypertension
Intervention:  
Sponsors:   Actelion;   Canadian Heart Research Centre
Active, not recruiting - verified February 2016

Early TIPS With Polytetrafluoroethylene (PTFE) Covered Stents for High Risk Acute Variceal Bleeding in Cirrhotic Patients

Conditions:   Decompensated Cirrhosis;   Bleeding Varices
Interventions:   Procedure: Transjugular intrahepatic portosystemic shunt;   Drug: Non-selective beta blocker + Endoscopic treatment
Sponsor:   Fourth Military Medical University
Recruiting - verified February 2016

Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529

Condition:   Hypertension, Pulmonary
Intervention:   Drug: Ambrisentan
Sponsor:   GlaxoSmithKline
Recruiting - verified December 2015

The Role of a Combination of Nutraceuticals in the Control of Cardiovascular Risk

Condition:   Metabolic Syndrome
Intervention:   Drug: Armolipid Prev
Sponsor:   Federico II University
Completed - verified February 2016

The Health Outcomes Management and Evaluation (HOME) Study

Conditions:   Diabetes;   Hyperlipidemia;   Heart Disease;   High Blood Pressure
Intervention:   Other: Care team
Sponsors:   Emory University;   National Institute of Mental Health (NIMH)
Completed - verified February 2016

Effect of BMPR-2 Gene Mutations on Hemodynamic Response by Iloprost Inhalation in Pulmonary Arterial Hypertension

Condition:   Pulmonary Arterial Hypertension
Intervention:   Drug: Iloprost
Sponsors:   Gachon University Gil Medical Center;   Seoul National University Hospital;   Seoul National University Bundang Hospital;   The Catholic University of Korea;   Bayer
Recruiting - verified February 2016

A Study of the Pharmacokinetics and Pharmacodynamics of MK1809 (1809-001)(COMPLETED)

Condition:   Hypertension
Interventions:   Drug: MK1809;   Drug: Comparator: Losartan;   Drug: Comparator: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified February 2016

Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis

Conditions:   Psoriasis;   Cardiovascular Diseases;   Dyslipidemia
Intervention:  
Sponsor:   George Washington University
Recruiting - verified February 2016

Genetic Mechanisms in Human Hypertension Renin-angiotensin-aldosterone System (RAAS) Inhibition Study

Condition:   Hypertension
Intervention:   Drug: Lisinopril, Atenolol
Sponsors:   Brigham and Women's Hospital;   University of Utah
Active, not recruiting - verified February 2016

Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis

Condition:   Myasthenia Gravis
Intervention:   Drug: Prednisone - Azathioprine
Sponsor:   Assistance Publique - Hôpitaux de Paris
Active, not recruiting - verified July 2015

A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis

Conditions:   Psoriasis;   Nonalcoholic Fatty Liver Disease
Intervention:  
Sponsor:   George Washington University
Recruiting - verified February 2016

Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients

Condition:   Primary Open Angle Glaucoma (POAG)
Interventions:   Device: Perimetry;   Device: Confocal Scanning Laser Tomography;   Device: Optical Coherence Tomography (OCT)
Sponsors:   University Hospital Tuebingen;   Alcon Research
Active, not recruiting - verified January 2016

Effect of CPAP on Blood Pressure in Patients With Sleep Apnea and Refractory Hypertension

Conditions:   Obstructive Sleep Apnea;   Refractory Arterial Hypertension
Interventions:   Device: CPAP;   Device: Control
Sponsors:   Corporacion Parc Tauli;   Carlos III Health Institute
Recruiting - verified February 2016

Polycystic Kidney Disease Data Repository

Condition:   Polycystic Kidney Disease
Intervention:  
Sponsors:   The Rogosin Institute;   Weill Medical College of Cornell University;   New York Presbyterian Hospital
Recruiting - verified February 2016

Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk Factors

Conditions:   Hypertension;   Dyslipidemia;   Hyperglycemia
Intervention:   Dietary Supplement: Xocai Activ drink
Sponsor:   University of Utah
Completed - verified April 2008

Effect of Aerobic Exercise on Blood Pressure Changes

Conditions:   Hypertension;   Cardiovascular Diseases
Interventions:   Behavioral: Aerobic Conditioning Program;   Behavioral: Strength Training Program
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified December 2007

Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Biliopancreatic Diversion (BPD)- Duodenal Switch for Superobesity

Conditions:   Obesity;   Diabetes;   Hypertension
Interventions:   Procedure: Laparoscopic Biliopancreatic diversion with Duodenal switch;   Procedure: Laparoscopic Roux-en-Y Gastric Bypass
Sponsors:   Göteborg University;   Helse Sor-Ost
Active, not recruiting - verified February 2016

Conditioned Placebo Effects and Treatment of Hypertension

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Interventions:   Drug: antihypertensive drug;   Behavioral: placebo
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified January 2008

Stepped Intervention for Meds Adherence and Blood Pressure Control

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:   Behavioral: self-medication monitoring
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified January 2008

Genetic and Environmental Characteristics of Primary Pulmonary Hypertension

Conditions:   Lung Diseases;   Hypertension, Pulmonary
Intervention:  
Sponsors:   Vanderbilt University;   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified February 2016

ACE Inhibition and Novel Cardiovascular Risk Factors

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:   Drug: Fosinopril
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified January 2008

Cardiac and Renal Disease Study (CARDS)

Conditions:   Coronary Disease;   Cardiovascular Diseases;   Cerebrovascular Accident;   Heart Failure;   Heart Diseases;   Peripheral Vascular Diseases;   Diabetes Mellitus;   Hypertension;   Kidney Failure, Chronic
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified January 2006

Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye Study

Conditions:   Atherosclerosis;   Cardiovascular Diseases;   Coronary Arteriosclerosis;   Coronary Disease;   Cerebrovascular Disorders;   Heart Failure, Congestive;   Myocardial Infarction;   Heart Diseases;   Diabetes Mellitus, Non-insulin Dependent;   Hypertension;   Diabetic Retinopathy;   Macular Degeneration;   Diabetes Mellitus
Intervention:  
Sponsors:   University of Wisconsin, Madison;   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified February 2016

Prenatal Nutrition and Adult Disease

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Diabetes Mellitus;   Diabetes Mellitus, Non-insulin Dependent;   Insulin Resistance;   Obesity;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified January 2008

Pulmonary Hypertension--Mechanisms and Family Registry

Conditions:   Lung Diseases;   Hypertension, Pulmonary
Intervention:  
Sponsors:   Vanderbilt University;   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified February 2016

Improving Hypertension Control in the Inner City

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   Medical College of Wisconsin
Completed - verified February 2016

Urban African-American Community Hypertension Control

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified May 2002

Hypertension in Families of African Origin

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified July 2004

Opioid Compromise in Hypertension--Modulating Factors

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified May 2000

End-organ Pathology in Childhood Essential Hypertension

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified May 2000

Improving Adherence to Interventions for Hypertension

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension;   Obesity
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified July 2000

Epidemiology of Persistent Pulmonary Hypertension of the Newborn - SCOR in Lung Biology and Diseases in Infants and Children

Conditions:   Lung Diseases;   Cardiovascular Diseases;   Defect, Congenital Heart;   Heart Diseases;   Persistent Fetal Circulation Syndrome
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified October 2001

Insulin and Biogenic Amines in Cardiovascular Disease

Conditions:   Cardiovascular Diseases;   Hypertension;   Heart Diseases;   Obesity;   Myocardial Infarction;   Insulin Resistance
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified June 2000

Adolescent Blood Pressure Variation and Ventricular Mass

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified April 2000

Central Obesity and Disease Risk in Japanese Americans

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Atherosclerosis;   Hypertension;   Obesity;   Diabetes Mellitus, Non-insulin Dependent;   Hyperinsulinism;   Insulin Resistance;   Coronary Arteriosclerosis;   Diabetes Mellitus;   Metabolic Syndrome X
Intervention:  
Sponsors:   University of Washington;   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified August 2004

Proarrhythmic Medicines and Primary Cardiac Arrest

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Heart Arrest;   Hypertension;   Arrhythmia
Intervention:  
Sponsors:   University of Washington;   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified January 2006

Minnesota Heart Survey - Risk Factor Survey

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Cerebrovascular Accident;   Coronary Disease;   Hypertension;   Myocardial Infarction
Intervention:  
Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified February 2016

Biobehavioral Mechanisms of Blood Pressure Regulation

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified April 2001

Evaluation of Childhood Blood Pressure and Lipid Screening

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypercholesterolemia;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified May 2000

Race, Class, and Gender--Studies of Health Effects

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified July 2000

Divergence of Blood Pressure By Race in Adolescent Girls

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension;   Obesity
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified August 2004

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Coronary Disease;   Cerebrovascular Disorders;   Diabetes Mellitus;   Hypertension;   Cerebrovascular Accident
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified January 2008

PREMIER: Lifestyle Interventions for Blood Pressure Control

Conditions:   Heart Diseases;   Hypertension
Interventions:   Behavioral: diet, sodium-restricted;   Behavioral: diet, fat-restricted;   Behavioral: exercise;   Behavioral: diet, reducing;   Behavioral: alcohol drinking
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified November 2005